Acumen Hypotension Prediction Index (HPI) Feature Software vs Ligence Heart

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

Acumen Hypotension Prediction Index (HPI) Feature Software

by Edwards Lifesciences

Ligence Heart

by Ligence

AI Verdict

Tool A is a predictive monitoring tool focused on detecting and preventing hypotensive events in critical care, utilizing real-time physiological data. In contrast, Tool B is an AI-powered platform designed to automate the analysis and reporting of echocardiography images, enhancing diagnostic efficiency for cardiologists. While both fall under Cardiology AI, they address distinct clinical problems and workflows.

Choose Acumen Hypotension Prediction Index (HPI) Feature Software if…

Choose Acumen Hypotension Prediction Index (HPI) if your primary need is proactive, real-time management of patient hemodynamics to prevent hypotensive events in critical care or surgical settings. This tool is ideal for clinicians who require early warnings and insights into preload, afterload, and contractility to intervene before blood pressure drops significantly.

View Acumen Hypotension Prediction Index (HPI) Feature Software →

Choose Ligence Heart if…

Choose Ligence Heart if your goal is to enhance the efficiency and accuracy of 2D transthoracic echocardiography analysis and reporting. This platform is best suited for cardiology departments and sonographers looking to automate measurements, classify views, and generate comprehensive reports, thereby streamlining diagnostic workflows and standardizing interpretation.

View Ligence Heart →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	Acumen Hypotension Prediction Index (HPI) Feature Software	Ligence Heart
Pricing	Unknown	Contact-for-pricing
Deployment	Unknown	Cloud-based; on-premise; hybrid
BAA Available	Unknown	Yes AI-estimated
FDA Status	Cleared AI-estimated	Cleared AI-estimated
HIPAA	Yes AI-estimated	Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Ligence Heart

Ligence Heart is a web-based platform that automates the complex analysis and reporting of 2D transthoracic echocardiography, including view classification, measurements, and report generation. This significantly reduces manual effort and standardizes reporting, enhancing efficiency for cardiologists and sonographers. While Acumen HPI offers a streamlined workflow within its integrated monitoring platform, Ligence Heart's comprehensive automation of a time-consuming diagnostic process provides a more substantial leap in usability for its target users.

Clinical Value

Acumen Hypotension Prediction Index (HPI) Feature Software

Acumen HPI demonstrates a direct impact on patient safety by predicting hypotension up to 15 minutes before an event and has shown a reduction in the incidence, duration, and severity of intraoperative hypotension. This proactive intervention capability directly improves patient outcomes in critical care settings. While Ligence Heart enhances diagnostic efficiency and accuracy, Acumen HPI's ability to prevent critical adverse events in real-time offers a more immediate and tangible clinical benefit.

Pricing & Value

Tie

Both Acumen HPI and Ligence Heart maintain opaque pricing models, requiring direct contact with their respective vendors for pricing information. Without transparent pricing details for either product, it is impossible to conduct a meaningful head-to-head comparison of their cost-effectiveness or overall value proposition. Therefore, a definitive winner cannot be determined in this dimension.

Enterprise Readiness

Ligence Heart

Ligence Heart offers flexible deployment options, including cloud-based, on-premise, and hybrid models, and explicitly supports integration with existing hospital systems like PACS, EHR, and RIS. This broad compatibility and integration capability make it highly adaptable for diverse healthcare IT environments. Acumen HPI, while FDA cleared and HIPAA compliant, is integrated into a specific proprietary platform, which may limit its readiness for organizations not already using that ecosystem.

Innovation

Acumen Hypotension Prediction Index (HPI) Feature Software

Acumen HPI is described as a 'first-of-its-kind technology' that uses machine learning to predict hypotension up to 15 minutes in advance, enabling proactive treatment of hemodynamic instability. This predictive capability for a critical, time-sensitive physiological event represents a groundbreaking advancement in proactive patient management. While Ligence Heart's automation of echocardiography analysis is highly innovative, Acumen HPI's direct impact on preventing life-threatening events gives it an edge in terms of novel and critical application.

Support & Docs

Ligence Heart

Ligence Heart explicitly details various support and documentation resources, including an Instructions for Use (IFU) in PDF format, a Software Installation Manual, dedicated email for technical support, and the provision of training videos to operators. While Acumen HPI implies the availability of instructions for use, Ligence Heart offers a more transparent and comprehensive outline of its support and documentation structure.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	Acumen Hypotension Prediction Index (HPI) Feature Software	Ligence Heart
Tool Name	Acumen Hypotension Prediction Index (HPI) Feature Software	Ligence Heart
Company	Edwards Lifesciences	Ligence
Primary Function	Predictive monitoring tool that uses machine learning to detect and alert clinicians to the likelihood of a hypotensive event before it occurs.	AI-powered web-based platform that automates the analysis and reporting of 2D transthoracic echocardiography.
Key Feature Example 1	Hypotension Prediction Index (HPI) parameter (0-100 score) and prediction of hypotension up to 15 minutes before an event.	Automated recognition of echocardiography imaging data, view classification, and heart phase prediction.
Key Feature Example 2	Smart Alerts and Smart Trend screen for impending hypotensive events, and Relationship View screen for preload, afterload, and contractility.	Automated calculation of measurements, report generation, and disease recognition (e.g., Heart failure, cardiomyopathy).
Specialties	Anesthesiology, Critical Care, Emergency Medicine	Cardiology
Categories	Cardiology AI, Triage & ER/ICU AI	Cardiology AI

Videos

Demos, reviews, and walkthroughs featuring Acumen Hypotension Prediction Index (HPI) Feature Software and Ligence Heart.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How do these tools integrate into existing clinical workflows and what is their expected impact on physician efficiency and decision-making?

Acumen HPI integrates into the Edwards Lifesciences HemoSphere advanced monitoring platform, providing real-time HPI scores and Smart Alerts to aid proactive hemodynamic management. This aims to streamline decision-making by alerting clinicians to impending hypotensive events up to 15 minutes in advance. Ligence Heart is a web-based platform that automates the analysis and reporting of 2D transthoracic echocardiography, integrating seamlessly with existing PACS, EHR, and RIS systems. This automation enhances diagnostic efficiency by reducing manual measurement and report generation time for cardiologists and sonographers.

What specific clinical benefits and improvements in diagnostic accuracy can physicians expect from each tool, and what evidence supports these claims?

Acumen HPI is demonstrated to reduce the incidence, duration, and severity of intraoperative hypotension by predicting events up to 15 minutes prior, with high sensitivity and specificity. This proactive approach supports improved patient outcomes in critical care and surgical settings. Ligence Heart enhances diagnostic accuracy for echocardiography by automating measurements and disease recognition for conditions like heart failure and valvular diseases. This automation aims to provide consistent and precise analysis, with accuracy non-inferior to a cardiologist, improving the reliability of echo reports.

For which medical specialties are these tools primarily designed, and what is the anticipated learning curve for physicians to effectively utilize their features?

Acumen HPI is primarily designed for Anesthesiology, Critical Care, and Emergency Medicine, integrating into an existing monitoring platform. The learning curve is tied to understanding the HPI score and alert system within a familiar environment, with an FDA-mandated usability study confirming its effectiveness. Ligence Heart is tailored for Cardiology, automating complex echocardiography tasks through a web-based platform. Its intuitive interface and automated processes aim to simplify the workflow and potentially reduce the learning curve associated with manual analysis for cardiologists and sonographers.

Beyond standard compliance, what specific measures are in place to protect patient data, and what audit-trail features are available for clinical accountability and review?

For Acumen HPI, the provided information does not detail specific security measures beyond HIPAA compliance or explicit audit-trail features, though Edwards Lifesciences is committed to keeping personal data protected and secure. Ligence Heart explicitly states the transfer of echocardiography images with PHI removed from hospital PACS, indicating a focus on de-identification for data security. Ligence also has a Data Protection Officer and a process for reporting security breaches, though specific audit-trail features beyond general quality management system areas like auditing are not detailed.

What are the key considerations for deploying these tools across multiple hospital sites, and how do they support scalability within a larger healthcare system?

As an integrated feature within the Edwards Lifesciences HemoSphere advanced monitoring platform, multi-site rollout for Acumen HPI would likely align with the existing deployment and scalability strategies of the HemoSphere system. Ligence Heart offers flexible deployment options including cloud-based, on-premise, and hybrid models, which provides versatility for scaling across various hospital sites and integrating into diverse IT infrastructures. Ligence also aims to streamline cardiac imaging workflows and enhance diagnostic precision across clinical environments, supporting broader global expansion.